Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy

Completed

• Conditions: Suprachoroidal Hemorrhage (Diagnosis); Pars Plana Vitrectomy

• Registration Number: NCT05013281
• Lead Sponsor: Beijing Tongren Hospital

Brief Summary

To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV).

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01-01
• Primary Completion: 2020-06-30
• Study Completion: 2021-01-28
• Status Verified: 2021-07
• Study First Submitted: 2021-08-11
• Study First Submitted QC: 2021-08-17
• Last Update Submitted: 2021-08-17
• Study First Posted: 2021-08-19
• Last Update Posted: 2021-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

• Suprachoroidal hemorrhage associated with pars plana vitrectomy

Exclusion Criteria

• Patients with eye trauma-related Suprachoroidal hemorrhage were excluded.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pathogenesis	baseline	pathogenesis of PPV-related SCH and incidence of PPV-related SCH

Secondary Outcome Measures

Name	Time	Method
vision acuity	up to 7 weeks	the final vision acuity

Trial Locations

Locations (1)

Beijing Tongren Hospital; 🇨🇳 Beijing, Beijing, China